Bilateral Acute Depigmentation of Iris (BADI) and Bilateral Acute Iris Transillumination (BAIT)Following Acute COVID-19 Infection

References

• Sen M, Honavar SG, Sharma N, Sachdev MS. COVID-19 and eye: a review of ophthalmic manifestations of COVID-19. Indian J Ophthalmol. 2021 Mar;69(3):488–509. doi:10.4103/ijo.IJO_297_21.
   PubMed Web of Science ®Google Scholar
• Chen L, Liu M, Zhang Z, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol. 2020;104:748–751. doi:10.1136/bjophthalmol-2020-316304.
   PubMed Web of Science ®Google Scholar
• Tohamy D, Sharaf M, Abdelazeem K, et al. Ocular manifestations of post-acute COVID-19 syndrome, upper egypt early report. J MultidiscipHealthc. 2021;14:1935–1944. Published 2021 Jul 23 doi:10.2147/JMDH.S323582.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Urgancioglu M. Bilateral acute depigmentation of the iris. Graefes Arch Clin Exp Ophthalmol. 2006;244:742–746. doi:10.1007/s00417-005-0137-x.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Araz B, Taskapili B, et al. Bilateral acute depigmentation of the iris: report of 26 new cases and four year follow-up of two patients. Ophthalmology. 2009;116:1552–1557. doi:10.1016/j.ophtha.2009.02.019.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Onal S, Garip A, et al. Bilateral acute iris transillumination. Arch Ophthalmol. 2011;129(10):1312–1319. doi:10.1001/archophthalmol.2011.310.
   PubMedGoogle Scholar
• Bringas Calvo R, Iglesias Cortin˜as D. Acute and bilateral uveitis secondary to moxifloxacin [in Spanish]. Arch Soc Esp Oftalmol. 2004;79(7):357–359. doi:10.4321/s0365-66912004000700011.
   PubMedGoogle Scholar
• Wefers Bettink-Remeijer M, Brouwers K, van Langenhove L, et al. Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin. Eye (Lond). Dec 2009;23(12):2260–2262. doi:10.1038/eye.2009.234.
   PubMed Web of Science ®Google Scholar
• Willermain F, Deflorenne C, Bouffioux C, Janssens X, Koch P, Caspers L. Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin. Eye (Lond). 2010 Aug;24(8):1419. author reply 1419–1420. doi:10.1038/eye.2010.19.
   PubMed Web of Science ®Google Scholar
• Altan C, Basarir B, Kesim C. An unexpected complication in bilateral acute iris transillumination: cystoid macular edema. Indian J Ophthalmol. 2018 Jun;66(6):869–871. doi:10.4103/ijo.IJO_1134_17.
   PubMed Web of Science ®Google Scholar
• Knape RM, Sayyad FE, Davis JL. Moxifloxacin and bilateral acute iris transillumination. J Opthalmic Inflammation Infect. 2013;3:10. doi:10.1186/1869-5760-3-10.
   PubMedGoogle Scholar
• Yagci BA, Atas F, Kaya M, Arikan G. COVID-19 associated bilateral acute ıris transillumination. Ocul Immunol Inflamm. 2021 May 19;29(4):719–721. doi:10.1080/09273948.2021.1933073.
   PubMed Web of Science ®Google Scholar
• Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: a systematic review and meta-analysis. EClinicalMedicine. 2021 May 24;36:100899. doi:10.1016/j.eclinm.2021.100899.
   PubMedGoogle Scholar
• Braceros KK, Asahi MG, Gallemore RP. Visual snow-like symptoms and posterior uveitis following COVID-19 infection. Case Rep Ophthalmol Med. 2021;2021:6668552. doi:10.1155/2021/6668552.
   PubMed Web of Science ®Google Scholar
• Perone JM, Chaussard D, Hayek G. Bilateral acute iris transillumination (BAIT) syndrome: literature review. Clin Ophthalmol. 2019 Jun 5;13:935–943. doi:10.2147/OPTH.S167449.
   PubMed Web of Science ®Google Scholar
• Maestrini HA, Maestrini AA, Machado DDO, Santos DVV, Almeida HGD. Bilateral acute depigmentation of the iris (BADI): first reported case in Brazil. Arq Bras Oftalmol. 2013;76(1):42–44. doi:10.1590/S0004-27492013000100012.
   PubMed Web of Science ®Google Scholar
• Kawali A, Mahendradas P, Shetty R. Acute depigmentation of the iris: a retrospective analysis of 22 cases. Can J Ophthalmol. 2019;54(1):33–39. doi:10.1016/j.jcjo.2018.03.020.
   PubMed Web of Science ®Google Scholar
• Hinkle DM, Dacey MS, Mandelcorn E, et al. Bilateral uveitis associated with fluoroquinolone therapy. Cutan Ocul Toxicol. 2012;31(2):111–116. doi:10.3109/15569527.2011.617024.
   PubMed Web of Science ®Google Scholar
• Kreps EO, Hondeghem K, Augustinus A, et al. Is oral moxifloxacin associated with bilateral acute iris transillumination? Acta Ophthalmol. 2017. doi:10.1111/aos.13558.
   Web of Science ®Google Scholar
• Tranos P, Lokovitis E, Masselos S, Kozeis N, Triantafylla M, Markomichelakis N. Bilateral acute iris transillumination following systemic administration of antibiotics. Eye (Lond). 2018;32(7):1190–1196. doi:10.1038/s41433-018-0054-y.
   PubMed Web of Science ®Google Scholar
• Morshedi RG, Bettis DI, Moshirfar M, Vitale AT. Bilateral acute iris transillumination following systemic moxifloxacin for respiratory illness: report of two cases and review of the literature. Ocul Immunol Inflamm. 2012;20(4):266–272. doi:10.3109/09273948.2012.670359.
   PubMed Web of Science ®Google Scholar
• Gonul S, Bakbak B. Anterior uveitis due to intracameral moxifloxacin: a case report. Ocul Immunol Inflamm. 2020;29:1–4. doi:10.1080/09273948.2020.1797118.
   Web of Science ®Google Scholar
• Perone JM, Reynders S, Sujet-Perone N, et al. Le syndrome de transillumination bilatérale aiguë de l’iris: case report [Bilateral acute iris transillumination: case report]. J Fr Ophtalmol. 2017;40(8):713–716. French. doi:10.1016/j.jfo.2017.01.018.
   PubMed Web of Science ®Google Scholar
• Duncombe A, Gueudry J, Massy N, Chapuzet C, Gueit I, Muraine M. Severe pseudouveitis associated with moxifloxacin therapy. J Fr Ophtalmol. 2013;36(2):146–150. doi:10.1016/j.jfo.2012.07.002.
   PubMed Web of Science ®Google Scholar
• Siefert HM, Domdey-Bette A, Henninger K, Hucke F, Kohlsdorfer C, Stass HH. Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species. J Antimicrob Chemother. 1999;43(Suppl B):69–76. doi:10.1093/jac/43.suppl_2.69.
   PubMedGoogle Scholar
• Den Beste KA, Okeke C. Trabeculotomy ab interno with Trabectome as surgical management for systemic fluoroquinolone-induced pigmentary glaucoma: a case report. Medicine (Baltimore). 2017;96(43):e7936. doi:10.1097/MD.0000000000007936.
   PubMed Web of Science ®Google Scholar
• Hernández Pardines F, Serra Verdú MC, Font Juliá E, Molina Martin JC. Aqueous humor misdirection syndrome after glaucoma filtering surgery in patient with bilateral acute iris transillumination (BAIT) syndrome. Arch Soc Esp Oftalmol. 2018;93(9):444–446. doi:10.1016/j.oftal.2018.03.010.
   PubMedGoogle Scholar
• Bayraktar S, Oray M, Altan C, Basarir B, Izgi B, Tugal-Tutkun I. Long-term results of trabeculectomy with mitomycin-C in patients with bilateral acute ıris transillumination. J Glaucoma. 2019 Sep;28(9):797–802. doi:10.1097/IJG.0000000000001309.
   PubMed Web of Science ®Google Scholar